immunogenicity
Showing 26 - 50 of 8,992
Chikungunya Virus Infection Trial (PXVX0317 vaccine booster, Placebo booster)
Not yet recruiting
- Chikungunya Virus Infection
- PXVX0317 vaccine booster
- Placebo booster
- (no location specified)
Aug 18, 2023
Healthy Volunteers Trial in Changsha (Enterovirus Type 71 Vcacine)
Completed
- Healthy Volunteers
- Enterovirus Type 71 Vcacine
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jun 20, 2023
Rabies Trial in Thai Binh (RABIVAX-S)
Completed
- Rabies
- RABIVAX-S
-
Thai Binh, VietnamCDC Thai Binh
Jun 29, 2023
Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide
Recruiting
- Pneumococcal Disease
- 23-valent pneumococcal polysaccharide vaccine
- control pneumococcal polysaccharide vaccine
-
Chengdu, Sichuan, ChinaSichuan Center For Disease Control and Prevention
Sep 19, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
Chronic Graft-versus-host Disease (cGVHD) Trial in Aventura (AMG 592, Placebo)
Completed
- Chronic Graft-versus-host Disease (cGVHD)
- AMG 592
- Placebo
-
Aventura, FloridaResearch Site
May 16, 2023
Newborn Vaccine Immunogenicity Trial in Fajara, Goroka (Hepatitis B vaccine (HBV), Bacillus Calmette-Guérin (BCG))
Active, not recruiting
- Newborn Vaccine Immunogenicity
- Hepatitis B vaccine (HBV)
- Bacillus Calmette-Guérin (BCG)
-
Fajara, Gambia
- +1 more
Jan 12, 2023
COVID-19 Trial (CVXGA1)
Not yet recruiting
- COVID-19
- CVXGA1
- (no location specified)
Feb 17, 2023
Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza
Active, not recruiting
- Immune Response
- Safety
- bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
- quadrivalent influenza vaccine
-
Incheon, Seo-gu, Korea, Republic ofInternational St. Mary's hospital
Jul 28, 2023
COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))
Recruiting
- COVID-19
- SARS-CoV-2 DNA Vaccine (ICCOV)
-
Wong Chuk Hang, Hong KongGleneagles Hospital Hong Kong
Jun 16, 2023
Osteoporosis, Postmenopausal Trial in Yantai (Denosumab)
Recruiting
- Osteoporosis, Postmenopausal
- Denosumab
-
Yantai, Shandong, ChinaShandong Boan Biotechnology Co., Ltd.
May 2, 2023
Lymphoma Trial in Houston (PCV20)
Not yet recruiting
- Lymphoma
- PCV20
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2023
Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)
Not yet recruiting
- Influenza, Human
- sa-mRNA vaccine Dose 1
- +4 more
- (no location specified)
Sep 7, 2023
Yellow Fever, Immunization; Infection Trial in Portland (17D)
Not yet recruiting
- Yellow Fever
- Immunization; Infection
- 17D
-
Portland, OregonOregon Health & Science University
May 10, 2023
Coronavirus Trial (OVX033, Saline solution)
Not yet recruiting
- Coronavirus
- OVX033
- Saline solution
- (no location specified)
Nov 14, 2023
Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)
Not yet recruiting
- Iron Deficiency Anemia
- Iron-fortified cookies
- +3 more
- (no location specified)
Aug 30, 2023
Tetanus Trial in Bijie (TTVA, TT)
Not yet recruiting
- Tetanus
- TTVA
- TT
-
Bijie, Guizhou, ChinaCenter for Disease Control and Prevention, Qixingguan District,
Nov 7, 2023
Psoriasis Trial in Hefei (Secukinumab)
Recruiting
- Psoriasis
- Secukinumab
-
Hefei, Anhui, ChinaThe Second Hospital of Anhui Medical University
Feb 15, 2023
COVID-19, SARS-CoV-2 Infection Trial in United States (AZD9838, Licensed mRNA vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- AZD9838
- Licensed mRNA vaccine
-
Long Beach, California
- +4 more
Nov 24, 2023
Malaria Trial (R21/Matrix-M™)
Recruiting
- Malaria
- R21/Matrix-M™
-
Entebbe, UgandaMRC/UVRI & LSHTM Uganda Research Unit
Jan 13, 2023
Assess Immunogenicity of Nationally Authorized Homologous
Not yet recruiting
- COVID-19
- Immune Responses
- (no location specified)
Jan 31, 2023
Vaccine Reaction Trial in Jinhua, Quzhou (vaccinate with DTap, vaccinate with DT)
Not yet recruiting
- Vaccine Reaction
- vaccinate with DTap
- vaccinate with DT
-
Jinhua, Zhejiang, China
- +1 more
May 12, 2023
Vaccine Reaction Trial in Hangzhou, Jiaxing (vaccinate with DTaP, vaccinate with DT)
Not yet recruiting
- Vaccine Reaction
- vaccinate with DTaP
- vaccinate with DT
-
Hangzhou, Zhejiang, China
- +1 more
May 12, 2023
COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))
Completed
- COVID-19
- Recombinant Novel Coronavirus vaccine (CHO Cells)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jun 6, 2023